The post infection consequences of Covid-19 are only starting to be fully realized. Initially, studies indicated that patients with diabetes had a higher chance of serious complications from Covid-19. However, recent reports now suggest an increased risk of diabetes diagnosis after a Covid-19 infection. During this discussion of diabetes in the context of Covid-19, Dr. Kaufman explains why HbA1c testing is even more important in today’s healthcare landscape and explores the hypotheses and pathophysiology behind this recent trend.
Who Should Attend?
Point-of-care coordinators, nurses, diabetologists, physicians, endocrinologists, clinicians, patients, providers, and researchers
Attendees are entitled to P.A.C.E. credits from the ASCLS and/or ACCENT credits from the AACC
- Understand of the pathophysiology of diabetes
- How an infection or inflammation interacts with patients with diabetes
- Learn how Covid-19 altered diabetes assessment and management